Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 53.2B | 52.7B | 46.3B | 47.8B |
Cost of revenue | 47.0B | 46.6B | 42.4B | 42.7B |
Gross profit | 6.3B | 6.0B | 3.9B | 5.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.2B | 3.3B | 3.1B | 3.2B |
Operating income | 3.6B | 3.0B | 911.8M | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 322.8M | 367.9M | 363.7M | 278.4M |
Other income expense | — | — | — | — |
Pretax income | 3.6B | 2.8B | 695.9M | 2.5B |
Tax provision | 656.2M | 631.3M | 157.8M | 588.5M |
Net income | 2.9B | 2.2B | 538.1M | 1.9B |
Basic EPS | — | 7.8 | 1.9 | 7.0 |
Diluted EPS | — | 7.8 | 1.9 | 7.0 |
Basic average shares | — | 277.5M | 277.4M | 277.5M |
Diluted average shares | — | 277.5M | 277.4M | 277.5M |
EBITDA | 4.5B | 3.7B | 1.5B | 3.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |